Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18351 - 18375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	GCNA	93953	downregulated	[Disulfiram binds to Copper] which results in decreased expression of GCNA mRNA	Xq13.1	A21750
Copper	Approved Investigational	GCNT3	9245	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GCNT3 mRNA	15q22.2	A21749
Copper	Approved Investigational	GDAP2	54834	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GDAP2 mRNA	1p12	A21749
Copper	Approved Investigational	GEM	2669	downregulated	[Disulfiram binds to Copper] which results in decreased expression of GEM mRNA	8q22.1	A21750
Copper	Approved Investigational	GEM	2669	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GEM mRNA	8q22.1	A21749
Copper	Approved Investigational	GEMIN4	50628	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GEMIN4 mRNA	17p13.3	A21749
Copper	Approved Investigational	GEMIN5	25929	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GEMIN5 mRNA	5q33.2	A21749
Copper	Approved Investigational	GEMIN6	79833	downregulated	[Disulfiram binds to Copper] which results in decreased expression of GEMIN6 mRNA	2p22.1	A21750
Copper	Approved Investigational	GFPT1	2673	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GFPT1 mRNA	2p13.3	A21749
Copper	Approved Investigational	GGCT	79017	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GGCT mRNA	7p14.3	A21749
Copper	Approved Investigational	GINS1	9837	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GINS1 mRNA	20p11.21	A21749
Copper	Approved Investigational	GINS2	51659	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GINS2 mRNA	16q24.1	A21749
Copper	Approved Investigational	GINS3	64785	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GINS3 mRNA	16q21	A21749
Copper	Approved Investigational	GJC1	10052	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GJC1 mRNA	17q21.31	A21749
Copper	Approved Investigational	GLA	2717	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GLA mRNA	Xq22.1	A21749
Copper	Approved Investigational	GLB1L2	89944	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GLB1L2 mRNA	11q25	A21749
Copper	Approved Investigational	GLG1	2734	upregulated	[Disulfiram binds to Copper] which results in increased expression of GLG1 mRNA	16q23.1	A21750
Copper	Approved Investigational	GLI3	2737	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GLI3 mRNA	7p14.1	A21749
Copper	Approved Investigational	GLIPR1	11010	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GLIPR1 mRNA	12q21.2	A21749
Copper	Approved Investigational	GLRX	2745	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GLRX mRNA	5q15	A21749
Copper	Approved Investigational	GLRX2	51022	downregulated	[Disulfiram binds to Copper] which results in decreased expression of GLRX2 mRNA	1q31.2	A21750
Copper	Approved Investigational	GLUL	2752	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GLUL mRNA	1q25.3	A21749
Copper	Approved Investigational	GMNN	51053	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GMNN mRNA	6p22.3	A21749
Copper	Approved Investigational	GMPS	8833	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of GMPS mRNA	3q25.31	A21749
Copper	Approved Investigational	GNAL	2774	upregulated	[NSC 689534 binds to Copper] which results in increased expression of GNAL mRNA	18p11.21	A21749

Displaying entries 18351 - 18375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability